Last updated on May 2018

Moderato System: A Double-Blind Randomized Trial

Brief description of study

The purpose of this double blind randomized study is the evaluation of the safety and efficacy of the Moderato System. The Moderato pacemaker is indicated for patients who require a dual chamber pacemaker and also have hypertension, in order to reduce their blood pressure.

Clinical Study Identifier: NCT02837445

Contact Investigators or Research Sites near you

Start Over

Josef Aichinger, Prim. Mag.

Krankenhaus der Elisabethinen
Linz, Austria
  Connect »

Thomas Pezawas, Prof.

Medical University Vienna
Vienna, Austria
  Connect »

Riet Dierckx, MD

OLV Hospital Aalst
Aalst, Belgium
  Connect »

Yuval Mika, Ph.D.

ZNA Middelheim
Antwerp, Belgium
  Connect »

Carlo de Asmundis, Prof.

UZ Brussel - Heart Rhythm Management Center
Brussels, Belgium
  Connect »

Petr Neuzil, Prof.

Na Homolce Hospital
Prague, Czechia
  Connect »

Béla Merkely, Prof.

Semmelweis University Heart and Vascular Center
Budapest, Hungary
  Connect »

Andrejs Erglis, Prof.

P. Stradins Clinical University Hospital
Riga, Latvia
  Connect »

Yuval Mika, Ph.D.

Hospital of Lithuanian University of Health Science Kauno Klinikos
Kaunas, Lithuania
  Connect »

Germanas Marinskis, Prof.

Vilnius University Hospital Santariskiu Klinikos
Vilnius, Lithuania
  Connect »

Zbigniew Kalarus, Prof.

Silesian Center for Heart Diseases
Zabrze, Poland
  Connect »

John R Paisey, MD

Southampton General Hospital, University Hospital Southampton NHS Foundation Trust
Southampton, United Kingdom
  Connect »

Shaumik Adhya, MD

Medway NHS Foundation Trust
Gillingham, United Kingdom
  Connect »

Aldo Dr Rinaldi, MD

St Thomas Hospital
London, United Kingdom
  Connect »